Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$18,316,062
+$2,085,002 QoQ
Shares Held
72,119
+8.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#780
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HUB Investment Partners, LLC holds $120,989,044 across 14 Drug Manufacturers - General names. JNJ ranks #2 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
158,806 | $39,961,941 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
72,119 | $18,316,062 | |
| 3 | LLY |
ELI LILLY & Co
|
14,924 | $17,900,294 | |
| 4 | AZN |
Astrazeneca PLC
|
78,626 | $14,909,062 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
87,005 | $10,992,211 | |
| 6 | MRK |
Merck & Co., Inc.
|
51,940 | $6,674,290 | |
| 7 | PFE |
Pfizer Inc
|
197,054 | $4,745,060 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
39,485 | $2,275,125 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,316,062 | 72,119 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $16,231,060 | 66,401 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,922,975 | 67,277 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,444,648 | 67,116 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,759,394 | 50,798 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,829,472 | 47,211 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,549,887 | 52,205 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $8,091,007 | 49,926 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,022,403 | 48,046 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,400,128 | 46,780 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $10,177,911 | 64,935 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,658,071 | 49,169 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,804,124 | 35,066 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,054,180 | 26,156 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $3,385,143 | 19,163 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,996,839 | 18,345 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,938,678 | 16,555 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,707,365 | 15,276 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,770,820 | 16,197 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,499,858 | 15,479 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,586,088 | 15,698 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,726,895 | 16,592 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,795,705 | 11,410 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||